Regenerate Technology
Rigenera is a tissue fragmentation technology capable of obtaining tens of thousands of micrografts from any human tissue in minutes.
They can also be used intra-operatively by the surgeon to regenerate damaged tissue, such as skin, bone or cartilage.
The technology we’re talking about is found in a disposable medical device called the Rigeneracon – a sterile capsule inside which fragments of tissue harvested painlessly from the patient are placed and fragmented to obtain micrografts.
The latter have an average size of 50 microns and can be used by direct application in the area requiring regeneration.
Rigeneracon medical devices (class I) have a network of 100 hexagonal holes, each hole is delimited by 6 micro-blades designed for efficient sectioning of both hard and soft tissues.
Cell disaggregation of a tissue fragment (square mm is sufficient for regeneration of up to 200 square mm of tissue) is performed together with filtering that takes into account predefined dimensions, resulting in the micro-groove we want.
After a short time of cell disintegration (1-5 minutes depending on the type of tissue) the microbead concentrate is extracted from the device and is ready to be used, exactly in the right form to be introduced into the surfaces to be treated.
The founders of the Rigenera brand are doctors Antonio Graziano and Riccardo D’Aquino. They started clinical trials in 2006, and the first line of technical-surgical devices based on Rigenera technology was ready in 2013.
In Romania, at the time of launch, Ortokinetic Medical Centers are the only access to this innovative treatment for the specialties Orthopedics – Traumatology and Dermatology.